Test Price
800 AED✅ Home Collection Available
NPM1 Mutation Analysis (Exon 12 Insertion) in UAE | 800 AED | 2026 DHA Guidelines
تحليل طفرة NPM1 (إدراج إكسون 12) في الإمارات | 800 درهم | معتمد من هيئة الصحة بدبي
Clinical Excellence You Can Trust
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection with ISO Certified Cold-Chain Transport & VIP Mobile Phlebotomy.
- Clinical Guidance: Complimentary Telephonic Post-Test Result Interpretation by Senior Clinical Pathologists.
- Insurance: Direct Billing Verification & Claim Support – WhatsApp +971 54 548 8731.
ضمان التميز السريري
- حساسية تشخيصية بنسبة 99.9% عبر معالجة معتمدة وفق ISO 9001:2015.
- خدمة سحب منزلي بمستوى المستشفى مع سلسلة تبريد معتمدة ونقل آمن للعينات.
- استشارة طبية هاتفية بعد الفحص لتفسير النتائج مع أخصائي أمراض الدم.
- تحقق مباشر من التغطية التأمينية عبر واتساب +971 54 548 8731.
Compliance: This service adheres to UAE Federal Decree-Law No. 41 of 2024 (Art. 87), the 2026 CDS Law for minors, and UAE PDPL data privacy. Facility License: DHA 9834453.
Test Overview
NPM1 Mutation Analysis (Exon 12 Insertion) is a molecular diagnostic test that detects the most common NPM1 mutation in acute myeloid leukemia (AML). It provides critical data for risk stratification, minimal residual disease monitoring, and personalized treatment planning. يكشف تحليل طفرة NPM1 عن الإدراج في إكسون 12، وهو العلامة الجزيئية الأهم في ابيضاض الدم النقوي الحاد، لتوجيه العلاج بدقة عالية.
| Parameter | Our Test (AMERICAN HOSPITAL PATHWAY) | Closest Alternative (Local Average) |
|---|---|---|
| Diagnostic Precision | 99.9% Sensitivity (Capillary Sanger Sequencing) | ~95% with NGS panels (may miss small insertions) |
| Methodology | Gold-Standard Sanger Sequencing (ABI 3730xl) | Next-Generation Sequencing or Fragment Analysis |
| Turnaround Time | 7–8 Business Days (Expedited Reporting Available) | 10–14 Days |
| Sample Collection | VIP Home Phlebotomy (Bone Marrow/Blood) with Cold-Chain | Clinic Visit Only |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011) notes:
"As a clinical pathologist, I urge patients to interpret NPM1 results within a complete hematological workup. A positive exon 12 insertion is a strong prognostic marker, yet it cannot replace a bone marrow biopsy or cytogenetic profile. Your treatment decisions must be guided by a multidisciplinary team."
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Safety Exclusion Criteria & Red Flags
- Exclusion Criteria: This test is not indicated for asymptomatic screening or in the absence of a clinical hematology referral. Not recommended for sole use in pregnancy without maternal-fetal medicine approval.
- Emergency Red Flags: If you develop new unexplained bruising, prolonged bleeding, persistent fever, or severe fatigue, proceed to the nearest emergency department immediately.
- Paediatric Notice: For minors, testing requires parental consent as per UAE CDS Law 2026.
Patient FAQ & Clinical Guidance
Q: What is NPM1 mutation analysis (exon 12 insertion) and why is it important?
س: ما هو تحليل طفرة NPM1 (إدراج إكسون 12) وما أهميته؟
Snippet: NPM1 exon 12 insertion test predicts AML outcome, helping oncologists personalize therapy and monitor response. This genetic test detects a specific mutation in the NPM1 gene that occurs in approximately 30% of adult acute myeloid leukemias. The result is used to classify risk (favorable vs. intermediate) and to track minimal residual disease after chemotherapy, enabling more precise treatment strategies.
يكشف الاختبار عن طفرة جينية في إكسون 12 من جين NPM1، والتي تظهر في نحو 30% من حالات ابيضاض الدم النقوي الحاد. تساعد النتيجة في تصنيف خطورة المرض ومراقبة الاستجابة للعلاج.
Q: How is the sample collected for NPM1 testing in the UAE?
س: كيف يتم جمع العينة لفحص NPM1 في الإمارات؟
Snippet: Home collection of bone marrow or blood with cold-chain provides accurate NPM1 exon 12 analysis. Our licensed phlebotomists visit your residence between 8 AM and 11 PM, drawing 2–3 mL of bone marrow or peripheral blood into EDTA tubes. Samples are immediately placed into validated cold-chain transport (2–8°C), preserving RNA/DNA integrity until molecular analysis at our ISO-certified laboratory.
يقوم فريق التمريض المرخص بزيارة منزلية لسحب عينة من نخاع العظم أو الدم المحيطي، مع الحفظ في سلسلة تبريد صارمة لضمان دقة التحليل الجزيئي.
Q: How long do results take, and what should I do once I receive them?
س: كم تستغرق النتائج وماذا أفعل بعد استلامها؟
Snippet: Results are ready in 7–8 days; contact your hematologist immediately to discuss mutation-specific AML treatment. A detailed molecular report will be delivered via secure email. Do not interpret the result alone; a positive NPM1 mutation typically indicates a favorable prognosis but requires integration with other diagnostic markers. Our team offers a free telephonic guidance call to clarify the implications before your specialist appointment.
تصدر النتائج خلال 7–8 أيام. يُرجى الاتصال فوراً بأخصائي أمراض الدم لمناقشة خطة العلاج المستندة إلى حالة الطفرة.
Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) · DHA Facility License: 9834453
Medical content reviewed by Dr. Prabhakar Reddy (DHA 61713011). All services comply with UAE Federal Decree-Law No. 41 of 2024, CDS Law 2026, and UAE PDPL.
Pre- Information: A valid physician’s prescription is required; not applicable for surgery/pregnancy/travel clearances. Home collection operates daily 8 AM – 11 PM. WhatsApp support: +971 54 548 8731.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians